UNM
65
-7
PAYX
30
-2
AIV
37
-2
ZBH
42
-2
HPE
75
7
APH
56
7
MLM
67
4
SPG
48
2
SIG
46
2
SYF
74
5
WYNN
50
2
NWS
60
2
MA
55
4
PCAR
52
-10
AON
62
-5
JBHT
65
2
L
71
2
PH
62
2
BRK.B
33
-14
TXN
50
2
UNM
65
-7
PAYX
30
-2
AIV
37
-2
ZBH
42
-2
HPE
75
7
APH
56
7
MLM
67
4
SPG
48
2
SIG
46
2
SYF
74
5
WYNN
50
2
NWS
60
2
MA
55
4
PCAR
52
-10
AON
62
-5
JBHT
65
2
L
71
2
PH
62
2
BRK.B
33
-14
TXN
50
2
Financhill
Back

Unicycive Therapeutics, Inc. 10K Form

Sell
36

UNCY
Unicycive Therapeutics, Inc.

Last Price:
$5.57
Seasonality Move:
72.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UNCY News And Ratings

See the #1 stock for the next 7 days that we like better than UNCY

UNCY Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-6M
Price / Cash Flow: 0
Annual Sales: $1.80
Price / Book: 3.19

Profitability

EPS (TTM): -2.79780
Net Income (TTM): $-33.5M
Gross Margin: $-428K
Return on Equity: -166.6%
Return on Assets: -93.61%

Unicycive Therapeutics, Inc. Earnings Forecast

Key Unicycive Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 0 years.

Unicycive Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: UNCY
Website: unicycive.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 3.83
Quick Ratio: 3.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0.94

UNCY Technical Analysis vs Fundamental Analysis

Sell
36
Unicycive Therapeutics, Inc. (UNCY) is a Sell

Is Unicycive Therapeutics, Inc. a Buy or a Sell?